Launch of the Refined Diagnostics brand

“What if cancer diagnosis were available within minutes instead of days?”

This question has guided the work at Refined since the early days of the company. Over the past years, the team has developed advanced laser sources for Raman imaging and gradually expanded this expertise into complete imaging systems capable of generating molecular information from tissue in real time, directly in the operating room.

From the beginning, the goal has been to translate this technology into clinical tools that enable faster and more informative cancer diagnostics. Today, Refined is in active exchange with more than 40 hospitals, has completed a clinical study, and is preparing the path toward regulatory approval and the market entry of its Aquila imaging system.

To reflect this growing clinical focus, the company is introducing Refined Diagnostics as a new brand dedicated to the medical field. The brand is designed to speak directly to surgeons, pathologists, and hospitals who will use the technology in everyday clinical practice.

At the same time, Refined Laser Systems remains the technological foundation of the company. It will continue to develop and supply advanced laser platforms for researchers and industrial partners worldwide, while Refined Diagnostics represents the clinical translation of this technology.

The introduction of the new brand marks an important step in the company’s evolution from photonics innovation to clinical impact.